PHARMACOLOGICAL INJECTION FOR THE TREATMENT AND PREVENTION OF LIVER DISEASES IN ANIMALS Russian patent published in 2022 - IPC A61K31/198 A61K47/20 A61P1/16 

FIELD: veterinary medicine.

SUBSTANCE: invention relates to the field of veterinary medicine, in particular to veterinary pharmacology, and can be used for the treatment and prevention of liver pathologies of non-infectious origin in animals. An injectable agent for the treatment of hepatoses in animals is proposed, including a water-soluble extract of saltwort, dihydroquercetin, the amino acid L-ornithine, dimethyl sulfoxide, and water for injection. Additionally, the injection contains alpha-lipoic acid in the form of meglumine thioctate and macrogol-400 as a solubilizer in the following ratio, wt.%: extract of saltwort holmova 2.0-2.5; dihydroquercetin 0.8-1.0; L-ornithine 1.5-2.0; dimethyl sulfoxide 10.0-13.0; alpha-lipoic acid in the form of meglumine thioctate 1.2-1.5; macrogol-400 (polyethylene glycol PEG-400) 4.2-5.1; water for injection - the rest.

EFFECT: use of the invention will expand the range of injectable drugs for animals, and its use will improve the clinical condition, normalize the level of hepatoindicative enzymes, the size and structure of the liver, as well as increase the safety and productivity of animals due to the hepatoprotective and antitoxic effect of the claimed injectable agent.

1 cl, 2 tbl, 2 ex